Related Experiment Video

Updated: Apr 24, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

20.5K

Temozolomide in low-grade gliomas: living longer and better

Jeremy Rees

    Journal of Neurology, Neurosurgery, and Psychiatry
    |September 6, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    EpilepsyNeurooncologyTumours

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    29.3K
    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
    05:29

    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

    Published on: March 28, 2021

    2.3K

    Related Experiment Videos

    Last Updated: Apr 24, 2026

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    20.5K
    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    29.3K
    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
    05:29

    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

    Published on: March 28, 2021

    2.3K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    2.6K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    2.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Ovarian teratoma and the anti-N-methyl-D-aspartate receptor encephalitis paraneoplastic phenomenon: A systematic review and analysis of the literature.

    Surgical oncology·2026

    CAR-T cells in the treatment of neurological autoimmune diseases.

    Practical neurology·2026

    Adult Medulloblastoma Presenting With Audiovestibular Symptoms and an Alternating Unterberger Test.

    Cureus·2025

    Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567).

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025

    Clinical, Imaging and Neurogenetic Features of Patients with Gliomatosis Cerebri Referred to a Tertiary Neuro-Oncology Centre.

    Journal of personalized medicine·2023

    Prevalence, clinical characteristics and treatment response of tremor in chronic inflammatory demyelinating polyneuropathy.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Whole-body quantitative muscle MRI in myotonic dystrophy type 2: a sensitive tool for pattern recognition, disease stratification and objective assessment of clinical severity.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Epilepsy and education: a nationwide cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

    Journal of neurology, neurosurgery, and psychiatry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us